Skip to main content
Caplight Logo









AtomVie Global Radiopharma Inc.

AtomVie Global Radiopharma Inc.

Private
HamiltonHealthcare & Life Scienceshttps://www.atomvie.com/

Last Round

Series A

Jun 1, 2023

Total Funding Raised

$90M

Company Overview

AtomVie Global Radiopharma Inc. is a pharmaceuticals company operating as a contract development and manufacturing organization (CDMO) for the GMP manufacturing and worldwide distribution of radiopharmaceuticals.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clinical Trials, Pharma Supply Chain, Precision Medicine, Smart Manufacturing

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

radiopharmaceutical manufacturingCDMOcontract development and manufacturing organizationradiotherapeuticsradioligand therapyRLTGMP manufacturingradiopharmaceutical logisticstargeted cancer therapypharma supply chainclinical trial supplycommercial supplyprocess developmentregulatory supportdrug product manufacturing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

AtomVie Global Radiopharma Inc. Comparables

Compare AtomVie Global Radiopharma Inc. with similar companies based on industry and business-model similarity.

AtomVie Global Radiopharma Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Nucleus RadioPharma
90%
SpectronRx
84%
NorthStar Medical Radioisotopes, LLC
81%

AtomVie Global Radiopharma Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AJun 1, 2023

Key People

Founding team and executive leadership

Bruno Paquin

Chief Executive Officer

Executive Team

Patrick A. Lim

Chief Financial Officer

Executive Team

Dodi Adar M.Sc.

Chief Operating Officer

Executive Team

AtomVie Global Radiopharma Inc. Investors

Notable investors and investment history

AtomVie Global Radiopharma Inc. investors
InvestorRounds
Avego ManagementSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 20, 2026

    Monthly visitors grew 42% MoM, reaching 1.8K.

  • May 2, 2025

    Monthly visitors increased 145% MoM, reaching 2.1K.

Recent news

Latest coverage and updates

  • partners_withOct 15, 2026

    AtomVie Global Radiopharma Inc. partners with Jubilant Radiopharma to provide logistics, regulatory, and last-mile distribution services supporting AtomVie Global Radiopharma Inc.'s growing radiopharmaceutical portfolio through a United States pharmacy network, announced in Canada on Oct 15th '26.

  • expands_facilitiesSep 8, 2026

    AtomVie Global Radiopharma Inc. expanded facilities to Canada, Northern America, Americas on Sep 8th '26.

  • invests_into_assetsSep 7, 2026

    AtomVie Global Radiopharma Inc. invested into assets: radiopharmaceutical manufacturing facility in the amount of $160M in Hamilton, Ontario, Canada, Northern America, Americas on Sep 5th '26.

  • expands_facilitiesSep 4, 2026

    AtomVie Global Radiopharma Inc. expanded facilities to Hamilton, Ontario, Canada, Northern America, Americas on Sep 4th '26.

  • expands_facilitiesSep 4, 2026

    AtomVie Global Radiopharma Inc. expanded facilities to Hamilton, Ontario, Canada, Northern America, Americas on Sep 5th '26.

AtomVie Global Radiopharma Inc. Filings

Explore SEC and related filing metadata, where available.

AtomVie Global Radiopharma Inc. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about AtomVie Global Radiopharma Inc.'s valuation, stock price, and market status.

Is AtomVie Global Radiopharma Inc. a public or private company?

AtomVie Global Radiopharma Inc. is a private company.

What is the current stock price of AtomVie Global Radiopharma Inc.?

AtomVie Global Radiopharma Inc. is a private company, so its shares have no public market price. Caplight tracks AtomVie Global Radiopharma Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is AtomVie Global Radiopharma Inc. worth (valuation)?

Valuation information for AtomVie Global Radiopharma Inc. is not publicly available.

Can I buy AtomVie Global Radiopharma Inc. stock?

AtomVie Global Radiopharma Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was AtomVie Global Radiopharma Inc.'s last funding round?

AtomVie Global Radiopharma Inc.'s most recent funding round was Series A on June 1, 2023.

Who are the main investors in AtomVie Global Radiopharma Inc.?

Key investors in AtomVie Global Radiopharma Inc. include Avego Management.

Will AtomVie Global Radiopharma Inc. IPO soon?

No public IPO plans have been announced for AtomVie Global Radiopharma Inc..

How can I track AtomVie Global Radiopharma Inc. secondary market activity?

Caplight tracks bids, offers, and trades in AtomVie Global Radiopharma Inc.'s shares on secondary markets.

Firmographic Details

HeadquartersHamilton
Employee Range140
Year Founded2021
Last FundingJun 1, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?